首页> 外国专利> Quality Assessment of induced Pluripotent Stem Cells by reference to Distinctive patterns of splicing of Pluripotency

Quality Assessment of induced Pluripotent Stem Cells by reference to Distinctive patterns of splicing of Pluripotency

机译:参照多能性拼接的独特模式对诱导性多能干细胞的质量评估

摘要

Claim 1: Distinctive pattern of splicing that comprises at least one profile and splicing event of Alternative Splicing (as) selected from the group consisting of S15, S9, S18, S19, S23, S26, S30 and S32.Claim 9: Use of the distinctive pattern of splicing as defined in one of the preceding Claims, to determine the condition of Cell Pluripotency.Claim 1: a method for determining the State of Pluripotency cells or groups of cells that will test that comprises the steps of: (i) for each Cell or group of cells.To determine the profile of each Gene splicing and splicing pattern of Distinctive discriminatory; (ii) to calculate the score; and (iii) to compare the discriminatory score with the coordinates of the centroid of a Pluripotent Group and control Group of a differential control; in which Cells or groups of cells to be tested are classified as Pluripotent if your scoreDiscriminatory is closer to the centroid of the Pluripotent control Group centroid Group differential control, and which not otherwise classified as Pluripotent.Claim 17: The Method for determining the State of Pluripotency cells according to the claim that Stage 16, which correlate the distinctive pattern of splicing with the State of Pluripotency of the cells contains either: i) to compare the pattern of Jesus Vo and splicing with a distinctive pattern of splicing of Pluripotent cells.The determination of this distinctive pattern of splicing is similar to, or not statistically different,The distinctive pattern of splicing of Pluripotent cells indicates that these cells are Pluripotent; or (ii) calculate the score to compare the discriminatory and discriminatory score with the coordinates of the centroid of a group control of a Pluripotent and differentiated Group C Ontrol,The cells or groups of cells to be tested are classified as Pluripotent discriminatory if its score is closest to the cluster centroid to the centroid of the Pluripotent Control and differential control in the group are classified as other non Pluripotent Way.Claim 19: a Diagnostic kit comprising means for determining a distinctive pattern of splicing as defined in any of claims 1 to 8 cells.Claim 21: Composition which comprises a Reagent capable of detecting an alternative splicing event or combination of events of Alternative splicing as defined in any of claims 1 to 8 cells.
机译:权利要求1:独特的拼接图案,包括至少一个轮廓和替代拼接的拼接事件,选自由S15,S9,S18,S19,S23,S26,S30和S32组成的组。权利要求9:其用途。 11.根据前述权利要求之一所述的独特的剪接模式,以确定细胞多能性的状况。权利要求1:一种确定将测试的多能性细胞或细胞组的状态的方法,该方法包括以下步骤:(i)确定每个基因剪接的图谱和区分性剪接模式; (ii)计算分数; (iii)将鉴别分数与差异对照的多能组和对照组的质心坐标进行比较;第17条:确定状态的方法16.根据权利要求1所述的多能细胞,其将独特的剪接模式与细胞的多能性状态相关联的第16阶段包含以下任一条件:i)比较Jesus Vo和剪接与多能细胞的剪接独特模式的模式。这种独特的剪接模式的确定与统计上的相似或不同,多能干细胞的剪接独特模式表明这些细胞是多能的。或(ii)计算分数以将歧视性和歧视性分数与多能和分化的C组控制群的质心对照的质心坐标进行比较。如果要测试的细胞或细胞组的得分为多能性,则将其分类为多能性19.组中的诊断试剂盒,其包括确定如权利要求1至1中任一项所定义的独特的剪接模式的工具,该诊断试剂盒包括该组中距多能控制和质控最接近的簇质心。 21.权利要求21的组合物,其包含能够检测如权利要求1至8中任一项所定义的替代剪接事件或替代剪接事件的组合的试剂。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号